CAR T Set The Pace So All Can Win The Cell Therapy Race
The critical function of cells in disease has been recognized for centuries, but it has only been in the past century that scientists have explored the potential of cells as a treatment option. From the initial stem cell transplants to the current pipeline of advanced cell therapies, researchers and manufacturers have set the foundation for today's significant achievements in medicine.
Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva. Explore the past of building workflows to support CAR T cell therapy, the present of welcoming new cell types to cell therapy, and the future of optimizing cell therapy processes for both efficiency and accessibility.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.